India 'to approve GM potato'

India ‘to approve GM potato’ The commercial growing of a genetically modified potato which contains nutrients lacking in the diets of many of the poorest is expected to be approved in India within six months.


India ‘to approve GM potato’

India ‘to approve GM potato’ The commercial growing of a genetically modified potato which contains nutrients lacking in the diets of many of the poorest is expected to be approved in India within six months.


Genentech's Next Move

Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’ lives by five months, proving wrong skeptics who said the blood vessel-blocking drug would never work. Now the biotech pioneer is embarking on a bold strategy to dominate the cancer drug market for decades to […]


Genentech’s Next Move

Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’ lives by five months, proving wrong skeptics who said the blood vessel-blocking drug would never work. Now the biotech pioneer is embarking on a bold strategy to dominate the cancer drug market for decades to […]


GM crops 'good for developing countries'

GM crops ‘good for developing countries’ In a discussion paper out on Tuesday to coincide with a national GM debate in the UK, the influential Nuffield Council on Bio-ethics says the technology has the potential to increase crop yields and improve the livelihoods of poor people.


GM crops ‘good for developing countries’

GM crops ‘good for developing countries’ In a discussion paper out on Tuesday to coincide with a national GM debate in the UK, the influential Nuffield Council on Bio-ethics says the technology has the potential to increase crop yields and improve the livelihoods of poor people.


BIOTECH RALLIES

BIOTECH RALLIES The promise of new cancer therapies coming out of last week’s American Society of Clinical Oncology meeting in Chicago has helped restore vigor to the biopharmaceutical industry. It has also gotten a boost from a spate of new product approvals and generally upbeat earnings reports this year.


Financial Snapshot For May 2003: Yee Hah

Financial Snapshot For May 2003: Yee Hah The biotech sector has turned in a remarkable performance this year – especially in May, when the stocks took off like a rocket. And, so far, they’re still climbing…


BIOTECH TEMPERATURE RISES

BIOTECH TEMPERATURE RISES Investors are showing classic symptoms of biotech fever. They’re seizing on good news about drug trials, cheering new drug-related news and buying shares contagiously…


Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog